Editorial: Oversight at Pitt: Whither due diligence?
By Pittsburgh Tribune-Review,
Pittsburgh Tribune-Review
| 04. 26. 2006
A superstar at the University of Pittsburgh was not subjected to commonsensical oversight by his institution.
Gerald Schatten was senior author on a paper describing patient-matched stem cells created through human embryonic cloning.
The research, conducted by Hwang Woo-Suk in South Korea, later was proven an extraordinary fraud.
It is clear Pitt's standards were substandard. The Institutional Review Board took Mr. Schatten at his word that none of the women whose eggs were harvested was identifiable to the researchers. The board, it appeared, did not have jurisdiction.
But it did.
South Korean law requires that families of women who donated eggs would have priority for any resulting treatments. So the researchers must have a way of identifying the donors. Actually, Hwang drove one, a lab assistant, to the hospital for the egg extraction. She later worked in Schatten's Pitt lab.
Strict ethical oversight protects the subjects' privacy and safety. Harvesting eggs is dangerous and questions persist whether the women gave informed consent.
Schatten may have believed all was well until it became impossible to say so with a straight face...
Related Articles
By Emma McDonald Kennedy
| 09.25.2025
In the leadup to the 2024 election, Donald Trump repeatedly promised to make IVF more accessible. He made the commitment central to his campaign, even referring to himself as the “father of IVF.” In his first month in office, Trump issued an executive order promising to expand IVF access. The order set a 90-day deadline for policy recommendations for “lowering costs and reducing barriers to IVF,” although it didn’t make any substantive reproductive healthcare policy changes.
The response to the...
Sir Francis Galton, 1890s, by Eveleen Myers (née Tennant)
npg.org
Public Domain via Wikipedia
As has been discussed in recent issues of Biopolitical Times (1, 2), there are, increasingly, companies that claim to be selling parents better babies by selecting the “best” embryos. These services don’t come cheap – think $50,000, or even more, for embryo testing, plus perhaps as much again for IVF and concomitant services. To most of us, that is extremely expensive...
By Margaux MacColl, The San Francisco Standard | 09.17.2025
Designer babies are coming soon to an IVF clinic near you.
Nucleus Genomics, founded by Kian Sadeghi in 2020, when he was just 20, got its start analyzing genomes to weigh a person’s risk of everything from cancer to ADHD...
By Marianne Lamers, NEMO Kennislink [cites CGS' Katie Hasson] | 09.23.2025
Een rijtje gespreide vulva’s gaapt de bezoeker aan. Zó ziet een bevalling eruit, en zó een baarmoeder met foetus. Een zwangerschap, maar dan zonder zwangere vrouw, gestript van zorgen, gêne en pijn. De zwangerschapsmodellen en oefenbekkens, te zien in de...